<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="is a RNA coronavirus responsible for the pandemic of the" exact="Severe" post="Acute Respiratory Syndrome (COVID-19). RNA viruses are characterized by"/>
 <result pre="a RNA coronavirus responsible for the pandemic of the Severe" exact="Acute" post="Respiratory Syndrome (COVID-19). RNA viruses are characterized by a"/>
 <result pre="RNA coronavirus responsible for the pandemic of the Severe Acute" exact="Respiratory" post="Syndrome (COVID-19). RNA viruses are characterized by a high"/>
 <result pre="coronavirus responsible for the pandemic of the Severe Acute Respiratory" exact="Syndrome" post="(COVID-19). RNA viruses are characterized by a high mutation"/>
 <result pre="mutagenic capability depends upon several factors, including the fidelity of" exact="viral" post="enzymes that replicate nucleic acids, as SARS-CoV-2 RNA dependent"/>
 <result pre="as SARS-CoV-2 RNA dependent RNA polymerase (RdRp). Mutation rate drives" exact="viral" post="evolution and genome variability, thereby enabling viruses to escape"/>
 <result pre="used to assess statistical significance. Results We characterized 8 novel" exact="recurrent" post="mutations of SARS-CoV-2, located at positions 1397, 2891, 14408,"/>
 <result pre="findings suggest that the virus is evolving and European, North" exact="American" post="and Asian strains might coexist, each of them characterized"/>
 <result pre="several drugs targeting RdRp enzymes are being employed for SARS-CoV-2" exact="infection" post="treatment. Some of them have a predicted binding moiety"/>
 <result pre="characterize SARS-CoV-2 RdRp mutation in order to assess possible drug-resistance" exact="viral" post="phenotypes. It is also important to recognize whether the"/>
 <result pre="rates. Keywords SARS-CoV-2 COVID-19 Mutation Drug resistance RdRp Europe RNA-dependent-RNA-polymerase" exact="Pneumonia" post="Viral mutagenesis Background The recent emergence of the novel,"/>
 <result pre="Keywords SARS-CoV-2 COVID-19 Mutation Drug resistance RdRp Europe RNA-dependent-RNA-polymerase Pneumonia" exact="Viral" post="mutagenesis Background The recent emergence of the novel, human"/>
 <result pre="mutagenesis Background The recent emergence of the novel, human pathogen" exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in China and"/>
 <result pre="Background The recent emergence of the novel, human pathogen Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in China and its"/>
 <result pre="The recent emergence of the novel, human pathogen Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2 (SARS-CoV-2) in China and its rapid"/>
 <result pre="recent emergence of the novel, human pathogen Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2 (SARS-CoV-2) in China and its rapid national"/>
 <result pre="two other RNA viruses that have caused recent important epidemics:" exact="Severe" post="Acute Respiratory Syndrome (SARS) caused by SARS-CoV, and the"/>
 <result pre="other RNA viruses that have caused recent important epidemics: Severe" exact="Acute" post="Respiratory Syndrome (SARS) caused by SARS-CoV, and the Middle"/>
 <result pre="RNA viruses that have caused recent important epidemics: Severe Acute" exact="Respiratory" post="Syndrome (SARS) caused by SARS-CoV, and the Middle East"/>
 <result pre="viruses that have caused recent important epidemics: Severe Acute Respiratory" exact="Syndrome" post="(SARS) caused by SARS-CoV, and the Middle East Respiratory"/>
 <result pre="Respiratory Syndrome (SARS) caused by SARS-CoV, and the Middle East" exact="Respiratory" post="Syndrome (MERS) by MERS-CoV. Noteworthy, some evidence has been"/>
 <result pre="Syndrome (SARS) caused by SARS-CoV, and the Middle East Respiratory" exact="Syndrome" post="(MERS) by MERS-CoV. Noteworthy, some evidence has been recently"/>
 <result pre="given day by the number of patients with confirmed SARS-CoV-2" exact="infection" post="14Â days before, considering the WHO data relative to"/>
 <result pre="number of deaths to March 1st, 2020 [1]. Differences in" exact="viral infection" post="rates can be due to a combination of factors,"/>
 <result pre="of deaths to March 1st, 2020 [1]. Differences in viral" exact="infection" post="rates can be due to a combination of factors,"/>
 <result pre="genetic population herd immunity. Mortality differences are to understand, but" exact="viral" post="mutations and evolution capability over time may be important."/>
 <result pre="correlated with virulence modulation and evolvability, traits considered beneficial for" exact="viral" post="adaptation [2]. Wang and coworkers have recently characterized 13"/>
 <result pre="mutation hotspots are emerging. RNA virus mutation rate contributes to" exact="viral" post="adaptation creating a balance between the integrity of genetic"/>
 <result pre="of genetic information and genome variability [4â€&quot;6]. Biological characterization of" exact="viral" post="mutations can provide precious insights for assessing viral drug"/>
 <result pre="characterization of viral mutations can provide precious insights for assessing" exact="viral" post="drug resistance, immune escape and pathogenesis related mechanisms. Additionally,"/>
 <result pre="viral drug resistance, immune escape and pathogenesis related mechanisms. Additionally," exact="viral" post="mutation studies can be crucial for designing new vaccines,"/>
 <result pre="for designing new vaccines, antiviral drugs and diagnostic assays. The" exact="viral" post="genome mutagenic process depends on the viral enzymes that"/>
 <result pre="diagnostic assays. The viral genome mutagenic process depends on the" exact="viral" post="enzymes that replicate the nucleic acids, influenced by few"/>
 <result pre="as determinants of the template sequence and structure involved in" exact="viral" post="replication. RNA-dependent RNA polymerases (RdRps) are multi-domain proteins able"/>
 <result pre="being produced as cleavage products of the ORF1a and ORF1b" exact="viral" post="polyproteins [10] to facilitate virus replication and transcription. The"/>
 <result pre="interaction have still to be identified. RdRps are considered among" exact="primary" post="targets for antiviral drug development, against a wide variety"/>
 <result pre="study on SARS-CoV-2 mutations in order to assess if new" exact="viral" post="variants were spreading across the Countries. This characterization of"/>
 <result pre="was deposited in January 2020 by Wu and coworkers [11]" exact="formerly" post="called â€œWuhan seafood market pneumonia virusâ€� (WSM, NC_045512) (https://www.ncbi.nlm.nih.gov/nuccore/NC_045512)."/>
 <result pre="by Wu and coworkers [11] formerly called â€œWuhan seafood market" exact="pneumonia" post="virusâ€� (WSM, NC_045512) (https://www.ncbi.nlm.nih.gov/nuccore/NC_045512). GISAID database (https://www.gisaid.org/) filtered from"/>
 <result pre="to March 13th, 2020 was used to collect 220 SARS-CoV-2" exact="complete" post="genomes of different patients all around the world (i.e."/>
 <result pre="consideration those deposited during the development of European outbreaks. Only" exact="complete" post="genomes (28000â€&quot;30,000 bps) were analyzed. Clustal Omega, Serial Cloner"/>
 <result pre="tests using 0.05 as the significance level. Results Identification of" exact="recurrent" post="mutation hotspots in different geographic areas A database of"/>
 <result pre="mutation hotspots in different geographic areas A database of 220" exact="complete" post="SARS-CoV-2 patient-isolated genome sequences randomly collected from the GISAID"/>
 <result pre="up to the 13th of March 2020. About 33.6% of" exact="complete" post="genomes belong to patients aged less than 44Â years"/>
 <result pre="1 SARS-CoV-2 mutation frequency in different geographic areas. Eight novel" exact="recurrent" post="hotspots mutations (namely 1397, 2891, 14408, 17746, 17857, 18060,"/>
 <result pre="given mutations present in each geographic area. Mutation locations in" exact="viral" post="genes are reported in the legend as well as"/>
 <result pre="mutations. The figure shows that genomes from European and North" exact="American" post="patients present an increase in mutation frequency compared to"/>
 <result pre="more than 10 times in our database. Those with a" exact="lower" post="occurrence were not reported. These mutations were found in"/>
 <result pre="in Europe and North America. We also noted that the" exact="viral" post="strains found in Europe and North America are derived"/>
 <result pre="account for each period of time) increases over time during" exact="viral" post="spread out of Asia (see Fig.Â 2). No mutations"/>
 <result pre="Mutation occurrence over time divided per geographic area. Eight novel" exact="recurrent" post="hotspots mutations (namely 1397, 2891, 14408, 17746, 17857, 18060,"/>
 <result pre="This figure shows that mutation frequency increases over time during" exact="viral" post="spread out of Asia. No mutations were observed in"/>
 <result pre="a different pattern of hotspot mutations is clearly distinguishable in" exact="viral" post="genomes detected in North American patients starting from March"/>
 <result pre="mutations is clearly distinguishable in viral genomes detected in North" exact="American" post="patients starting from March 2020, when the outbreak of"/>
 <result pre="18060â€&quot;light blue, purple and light pink, respectively) were reported. Interestingly," exact="viral" post="genomes present in North American patients carrying RdRp mutation"/>
 <result pre="pink, respectively) were reported. Interestingly, viral genomes present in North" exact="American" post="patients carrying RdRp mutation (14%) do not carry any"/>
 <result pre="the 23403 mutation (48.1%) and the 28881 mutation (+29.6%) (see" exact="upper" post="table Fig.Â 3). Fig.Â 3 Increment of SARS-CoV-2 mutation"/>
 <result pre="novel European mutation located at 14408 (in red) occurred. The" exact="upper" post="table shows the increment or decrement for each single"/>
 <result pre="group 2 have less than 2 mutations. We found that" exact="viral" post="strains with RdRp mutation have a median of 3"/>
 <result pre="have a median of 3 point mutations [range: 2â€&quot;5], whereas" exact="viral" post="strains with no RdRp mutation have a median of"/>
 <result pre="of 1 mutation [range: 0â€&quot;3] (p valueâ€‰ We found that" exact="viral" post="strains with RdRp mutation have a median of 3"/>
 <result pre="have a median of 3 point mutations [range: 2â€&quot;5], whereas" exact="viral" post="strains with no RdRp mutation have a median of"/>
 <result pre="ones in positions 17746, 17857 and 18060 (in North America)." exact="Viral" post="genomes carrying each one of these mutations were compared"/>
 <result pre="genomes carrying each one of these mutations were compared with" exact="viral" post="genomes without mutations, by using Mannâ€&quot;Whitney test for paired-groups"/>
 <result pre="particularly interesting given that the enzyme is directly involved in" exact="viral" post="replication and its fidelity determines the mutagenic capabilities of"/>
 <result pre="first locally transmitted SARS-CoV-2 cases out of Asia were reported," exact="viral" post="genomes presented different point mutations, clearly distinguishable within different"/>
 <result pre="geographic areas. Over time, we were able to identify three" exact="recurrent" post="mutations in Europe (in positions 3036, 14408 and 23403)"/>
 <result pre="mutation, located at position 14408, which is present in European" exact="viral" post="genomes starting from February 20th, 2020, is associated with"/>
 <result pre="associated with a higher number of point mutations compared to" exact="viral" post="genomes from Asia. Given that RdRp works in a"/>
 <result pre="complex machinery that includes proofreading activities (in cooperation with other" exact="viral" post="cofactors, like ExoN, nsp7 and nsp8), it is tempting"/>
 <result pre="to determine whether the mutation in RdRp results in increased" exact="viral" post="replication. Some polymerase inhibitors [29, 30] are currently being"/>
 <result pre="of 14408 mutation on the activity of RdRp and its" exact="susceptibility to" post="antiviral drugs. Conclusions We identified novel mutation hotspots in"/>
 <result pre="the described mutations could result in the emergence of drug-resistance" exact="viral" post="phenotypes. Our data may help the development of diagnostic"/>
 <result pre="mechanisms. Abbreviations RdRp RNA-dependent RNA polymerase nsp Non-structural protein SARS-CoV" exact="Severe" post="acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome"/>
 <result pre="Abbreviations RdRp RNA-dependent RNA polymerase nsp Non-structural protein SARS-CoV Severe" exact="acute" post="respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus"/>
 <result pre="RdRp RNA-dependent RNA polymerase nsp Non-structural protein SARS-CoV Severe acute" exact="respiratory" post="syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2"/>
 <result pre="RNA-dependent RNA polymerase nsp Non-structural protein SARS-CoV Severe acute respiratory" exact="syndrome" post="coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (COVID-19)"/>
 <result pre="nsp Non-structural protein SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2" exact="Severe" post="acute respiratory syndrome coronavirus 2 (COVID-19) MERS-CoV Middle east"/>
 <result pre="Non-structural protein SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe" exact="acute" post="respiratory syndrome coronavirus 2 (COVID-19) MERS-CoV Middle east respiratory"/>
 <result pre="protein SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute" exact="respiratory" post="syndrome coronavirus 2 (COVID-19) MERS-CoV Middle east respiratory syndrome"/>
 <result pre="SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory" exact="syndrome" post="coronavirus 2 (COVID-19) MERS-CoV Middle east respiratory syndrome coronavirus"/>
 <result pre="Severe acute respiratory syndrome coronavirus 2 (COVID-19) MERS-CoV Middle east" exact="respiratory" post="syndrome coronavirus ExoN Exonuclease WHO World Health Organization WSM"/>
 <result pre="acute respiratory syndrome coronavirus 2 (COVID-19) MERS-CoV Middle east respiratory" exact="syndrome" post="coronavirus ExoN Exonuclease WHO World Health Organization WSM Wuhan"/>
 <result pre="mutations and fitness for survivalAnnu Rev Microbiol199710.1146/annurev.micro.51.1.1519343347 7.BruennJAA structural and" exact="primary" post="sequence comparison of the viral RNA-dependent RNA polymerasesNucleic Acids"/>
 <result pre="Rev Microbiol199710.1146/annurev.micro.51.1.1519343347 7.BruennJAA structural and primary sequence comparison of the" exact="viral" post="RNA-dependent RNA polymerasesNucleic Acids Res200310.1093/nar/gkg27712654997 8.VenkataramanSPrasadBVLSSelvarajanRRNA dependent RNA polymerases:"/>
 <result pre="Top Microbiol Immunol200510.1007/3-540-26765-4_315609509 11.WuFZhaoSYuBet al.A new coronavirus associated with human" exact="respiratory" post="disease in ChinaNature202010.1038/s41586-020-2008-332296181 12.GaoYYanLHuangYet al.Structure of RNA-dependent RNA polymerase"/>
 <result pre="Microbiol Immunol200510.1007/3-540-26765-4_315609509 11.WuFZhaoSYuBet al.A new coronavirus associated with human respiratory" exact="disease" post="in ChinaNature202010.1038/s41586-020-2008-332296181 12.GaoYYanLHuangYet al.Structure of RNA-dependent RNA polymerase a"/>
 <result pre="15.EckerleLDBeckerMMHalpinRALiKVenterELuXScherbakovaSGrahamRLBaricRSStockwellTBSpiroDJDenisonMRInfidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by" exact="complete" post="genome sequencingPLoS Pathog201010.1371/journal.ppat.100089620463816 16.KirchdoerferRNWard AB structure of the SARS-CoV"/>
 <result pre="to nsp7 and nsp8 co-factorsNat. Comm201910.1038/s41467-019-10280-3 17.FurutaYGowenBBTakahashiKShirakiKSmeeDFBarnardDLFavipiravir (T-705), a novel" exact="viral" post="RNA polymerase inhibitorAntiviral Res201310.1016/j.antiviral.2013.09.01524084488 18.LimSYOsunaCLakritzJChenEYoonGTaylorRMacLennanSLeonardMGiulianoPMathisABergerEBabuYSheridanWWhitneyJGalidesivir, a direct-acting antiviral drug,"/>
 <result pre="Rhesus Macaques challenged with zika virusOpen Forum Infect Dis201710.1093/ofid/ofx162.12929354656 19.AgostiniMKAndreELSimsACGrahamRLSheahanTPLuXSmithECCaseJBFengJYJordanRRayASCihlarTSiegelDMackmanRLClarkeMOBaricRSDenisonMRCoronavirus" exact="susceptibility to" post="the antiviral remdesivir (GS-5734) is mediated by the viral"/>
 <result pre="susceptibility to the antiviral remdesivir (GS-5734) is mediated by the" exact="viral" post="polymerase and the proofreading exoribonucleaseMBio201810.1128/mBio.00221-1829511076 20.MorgensternBMichaelisMBaerPCDoerrHWCinatlJJrRibavirin and interferon-Î² synergistically"/>
 <result pre="for RIPK1Cell Rep201510.1016/j.celrep.2015.02.05225801024 34.YoungKCLindsayKLLeeKJLiuWCHeJWMilsteinSLLaiMMIdentification of a ribavirin-resistant NS5B mutation of" exact="hepatitis C" post="virus during ribavirin monotherapyHepatology200310.1053/jhep.2003.5044514512874 35.GoldhillDHte VelthuisAJWFletcherRALangatPZambonMLackenbyABarclayWSThe mechanism of resistance"/>
</results>
